Spanish Red Biotech Pipeline

Almirall

Lebrikizumab

Type: Biodrugs/ Drugs
Therapeutic area:
Indication: Atopic Dermatitis
Phase: 4Registration, 3Phase III, 2Phase II, 1Phase I, 2Regulatory Preclinical, 1Non Regulatory Preclinical